Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2017 3
2018 1
2021 2
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
New discoveries in the pathogenesis and classification of vitiligo.
Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE; Vitiligo Working Group. Rodrigues M, et al. J Am Acad Dermatol. 2017 Jul;77(1):1-13. doi: 10.1016/j.jaad.2016.10.048. J Am Acad Dermatol. 2017. PMID: 28619550 Review.
Vitiligo is a common autoimmune disease that progressively destroys melanocytes in the skin, resulting in the appearance of patchy depigmentation. ...Presentation patterns of vitiligo vary, and recognition of these patterns provides both diagnostic and prognostic cl
Vitiligo is a common autoimmune disease that progressively destroys melanocytes in the skin, resulting in the appearance of patchy de
Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force-Part 2: Specific treatment recommendations.
Seneschal J, Speeckaert R, Taïeb A, Wolkerstorfer A, Passeron T, Pandya AG, Lim HW, Ezzedine K, Zhou Y, Xiang F, Thng S, Tanemura A, Suzuki T, Rosmarin D, Rodrigues M, Raboobee N, Pliszewski G, Parsad D, Oiso N, Monteiro P, Meurant JM, Maquignon N, Lui H, Le Poole C, Leone G, Lee AY, Lan E, Katayama I, Huggins R, Oh SH, Harris JE, Hamzavi IH, Gupta S, Grimes P, Goh BK, Ghia D, Esmat S, Eleftheriadou V, Böhm M, Benzekri L, Bekkenk M, Bae JM, Alomar A, Abdallah M, Picardo M, van Geel N. Seneschal J, et al. Among authors: rodrigues m. J Eur Acad Dermatol Venereol. 2023 Nov;37(11):2185-2195. doi: 10.1111/jdv.19450. Epub 2023 Sep 15. J Eur Acad Dermatol Venereol. 2023. PMID: 37715487
BACKGROUND: The treatment of vitiligo can be challenging. Up-to-date agreed consensus recommendations on the use of topical and systemic therapies to facilitate the clinical management of vitiligo are currently lacking. ...CONCLUSIONS: This international consensus s …
BACKGROUND: The treatment of vitiligo can be challenging. Up-to-date agreed consensus recommendations on the use of topical and syste …
Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm.
van Geel N, Speeckaert R, Taïeb A, Ezzedine K, Lim HW, Pandya AG, Passeron T, Wolkerstorfer A, Abdallah M, Alomar A, Bae JM, Bekkenk M, Benzekri L, Böhm M, Eleftheriadou V, Esmat S, Ghia D, Goh BK, Grimes P, Gupta S, Hamzavi IH, Harris JE, Oh SH, Huggins R, Katayama I, Lan E, Lee AY, Leone G, Le Poole C, Lui H, Maquignon N, Meurant JM, Monteiro P, Oiso N, Parsad D, Pliszewski G, Raboobee N, Rodrigues M, Rosmarin D, Suzuki T, Tanemura A, Thng S, Xiang F, Zhou Y, Picardo M, Seneschal J. van Geel N, et al. Among authors: rodrigues m. J Eur Acad Dermatol Venereol. 2023 Nov;37(11):2173-2184. doi: 10.1111/jdv.19451. Epub 2023 Sep 25. J Eur Acad Dermatol Venereol. 2023. PMID: 37746876
BACKGROUND: The treatment of vitiligo can be challenging and depends on several factors such as the subtype, disease activity, vitiligo extent, and treatment goals. Vitiligo usually requires a long-term approach. To improve the management of vitiligo w …
BACKGROUND: The treatment of vitiligo can be challenging and depends on several factors such as the subtype, disease activity, vit
Current and emerging treatments for vitiligo.
Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE; Vitiligo Working Group. Rodrigues M, et al. J Am Acad Dermatol. 2017 Jul;77(1):17-29. doi: 10.1016/j.jaad.2016.11.010. J Am Acad Dermatol. 2017. PMID: 28619557 Review.
Clinicians should be aware that vitiligo is not merely a cosmetic disease and that there are safe and effective treatments available for vitiligo. ...
Clinicians should be aware that vitiligo is not merely a cosmetic disease and that there are safe and effective treatments available …
Expert Recommendations on Use of Topical Therapeutics for Vitiligo in Pediatric, Adolescent, and Young Adult Patients.
Renert-Yuval Y, Ezzedine K, Grimes P, Rosmarin D, Eichenfield LF, Castelo-Soccio L, Huang V, Desai SR, Walsh S, Silverberg JI, Paller AS, Rodrigues M, Weingarten M, Narla S, Gardner J, Siegel M, Ibad S, Silverberg NB. Renert-Yuval Y, et al. Among authors: rodrigues m. JAMA Dermatol. 2024 Apr 1;160(4):453-461. doi: 10.1001/jamadermatol.2024.0021. JAMA Dermatol. 2024. PMID: 38477910 Review.
IMPORTANCE: Evidence-based recommendations for the treatment of vitiligo in pediatric, adolescent, and young adult patients in the US are needed. OBJECTIVE: To develop evidence- and consensus-based expert recommendations on the diagnosis and treatment of vitiligo in …
IMPORTANCE: Evidence-based recommendations for the treatment of vitiligo in pediatric, adolescent, and young adult patients in the US …
Skin Cancer Risk (Nonmelanoma Skin Cancers/Melanoma) in Vitiligo Patients.
Rodrigues M. Rodrigues M. Dermatol Clin. 2017 Apr;35(2):129-134. doi: 10.1016/j.det.2016.11.003. Dermatol Clin. 2017. PMID: 28317522 Review.
The relative genetic and immune protection against melanoma and nonmelanoma skin cancers in those with vitiligo is reassuring. The results of recent studies allow us to be cautiously optimistic when discussing the risk of skin cancer caused by therapeutic exposure to narro …
The relative genetic and immune protection against melanoma and nonmelanoma skin cancers in those with vitiligo is reassuring. The re …
Expert opinion about laser and intense pulsed light (IPL)-induced leukoderma or vitiligo: a cross-sectional survey study.
Post NF, Van Broekhoven NX, Lommerts A, Bae JM, Bekkenk MW, de Castro CCS, Eleftheriadou V, Esmat S, Ezzedine K, van Geel N, Hamzavi I, Leone G, Pandya AG, Passeron T, Rodrigues MA, Seneschal J, Th'ng S, Wolkerstorfer A. Post NF, et al. Among authors: rodrigues ma. Arch Dermatol Res. 2023 Oct;315(8):2289-2294. doi: 10.1007/s00403-023-02611-8. Epub 2023 Mar 25. Arch Dermatol Res. 2023. PMID: 36964767 Free PMC article.
In a total of 11,300 vitiligo patients, laser/IPL-induced leukoderma or vitiligo was reported in 30 patients (0.27%). Of these, 12 (40%) patients had a medical history of vitiligo and seven (58%) of these patients had stable (> 12 months) vitiligo b …
In a total of 11,300 vitiligo patients, laser/IPL-induced leukoderma or vitiligo was reported in 30 patients (0.27%). Of these …
Integrating skin color assessments into clinical practice and research: A review of current approaches.
Harvey VM, Alexis A, Okeke CAV, McKinley-Grant L, Taylor SC, Desai SR, Jaleel T, Heath CR, Kang S, Vashi N, Lester J, Vasquez R, Rodrigues M, Elbuluk N, Hamzavi I, Kwatra SG, Sundaram H, Cobb C, Brown SG 3rd, Kohli I, Callender VD. Harvey VM, et al. Among authors: rodrigues m. J Am Acad Dermatol. 2024 Feb 9:S0190-9622(24)00215-9. doi: 10.1016/j.jaad.2024.01.067. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 38342247 Review.
Vitiligo is not a cosmetic disease.
Ezzedine K, Sheth V, Rodrigues M, Eleftheriadou V, Harris JE, Hamzavi IH, Pandya AG; Vitiligo Working Group. Ezzedine K, et al. Among authors: rodrigues m. J Am Acad Dermatol. 2015 Nov;73(5):883-5. doi: 10.1016/j.jaad.2015.07.039. J Am Acad Dermatol. 2015. PMID: 26475548 No abstract available.
Consensus on the safety and risks of laser and intense pulse light treatments in patients with vitiligo: An e-Delphi study.
Post NF, Rodrigues MA, Liong-A-Jin C, Lommerts A, Abdallah M, Bae JM, Bekkenk MW, Silva de Castro CC, Eleftheriadou V, Esmat S, Ezzedine K, van Geel N, Hamzavi I, Leone G, Pandya AG, Passeron T, Raboobee N, Seneschal J, Steven Th'ng, Wolkerstorfer A. Post NF, et al. Among authors: rodrigues ma. J Am Acad Dermatol. 2023 Aug;89(2):352-354. doi: 10.1016/j.jaad.2023.03.015. Epub 2023 Mar 24. J Am Acad Dermatol. 2023. PMID: 36967022 Free article. No abstract available.
15 results